|
- Hon Ian Macdonald MLC Minister for State Development (NSW)
- Professor Ian Frazer, Centre for Immunology & Cancer Research, University of Queensland (Qld)
- Dr Jackie Fairley, CEO, Starpharma (NSW)
- Dr Ian Nisbet, CEO, Xenome (NSW)
- Dr John Chiplin, CEO, Arana Therapeutics (NSW)
- Professor Silviu Itescu, Founder and Chief Scientific Advisor, Mesoblast (Vic)
- Justus Homburg, CEO, Progen (Qld)
- Dr Paul Tan, CEO, Living Cell Technologies (NSW)
- Dr Alan Robertson, CEO, Pharmaxis (NSW)
- Daniel Devine, Executive Director & CEO, Patrys*
- Professor Robert Clancy AM, Director and Chairman, Hunter Immunology Limited (NSW)
- Colin Mackie, Head of Corporate Development, Clinuvel Pharmaceuticals (Vic)
- Dr Simon Greenwood, Associate Director, Business Development, Genentech (California, USA)
- Dr Richard Boyd, Deputy Director, Department of Immunisation & Stem Cells, Monash University (Vic)
- Dr Daniel Grant, Head of Strategic Alliances, Pfizer (NSW)
- Stephen Patillo, Consultant, Asia Pacific, Indiana Economic Development Corporation (NSW)
- Matt McNarama, General Manager, Intersuisse Bioscience Managers (Vic)
- Michael O'Sullivan, Executive Director, Department of State and Regional Development (NSW)
- Dr Alan Robertson, CEO, Pharmaxis
- Dr Roslyn Brandon, CEO, Athlomics Pty Ltd
- Alison Coutts, Executive Director, eG Capital
- Professor James Dale, Chief Scientific Officer,
Farmacule Bioindustries & Queensland Biotechnology Advisory Council
- Dr Christophe Barbe, Chief Technical Officer, CeramiSphere P/L [ANSTO]
About the Australian Biotechnology Summit 2008
This is a flagship summit for the biotechnology industry - in Australia and internationally. The event has annually attracted a distinguished panel of speakers, as well as senior delegates representing the industry’s most innovative biotechnology companies. The agenda focuses on movng products from the bench to business, as well as R&D and full-scale commercialisation. The format features a mix of senior level presentations, “chat-room” style panel discussions and networking sessions. A state-of-the-art technology showcase is also included over the 2 days.
Why attend this flagship industry summit?
- 30+ CEO level presentations
- 20+ award-winning case studies - from Australia, Asia, Europe and North America
- 2-day technology showcase (complimentary)
- Interactive panel sessions
- Networking function (complimentary)
- Practical masterclass (optional)
Topics for inclusion in the July 2008 agenda will include:
- Medical advances & discoveries
- From the bench to business – R&D and full-scale commercialisation
- Expanding into global markets
- Venture capital and funding
- Investment opportunities
- Analysis of successes (and failures)
- Mergers and acquisitions/strategic alliances/partnerships
- Industry sustainability and challenges
- Government initiatives, regulation, legal framework
- Asset management, IP and patents
- Advances within publicly funded research
- Case studies from established listed companies to new listed start ups
- Global drug discoveries
- Funding & policy priorities
^ top ^ |
